Callan JMB financials
$2.28+3.17%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 |
|---|---|---|---|---|---|---|
| Revenue | $1.4M | $1.1M | $1.2M | $1.4M | $1.7M | $1.4M |
| Gross profit | $757.9K | $427.2K | $354.3K | $493.3K | $643.9K | $615.9K |
| Gross margin | 55.1% | 38.6% | 30.5% | 34.1% | 38.6% | 42.5% |
| Operating income | -$1.3M | -$1.7M | -$2.5M | -$1.9M | -$1.4M | -$1.2M |
| Net income | -$1.2M | -$3.2M | -$2.6M | -$2.7M | -$1.4M | -$1.2M |
| Net margin | −89.5% | −290.7% | −223.4% | −188.8% | −84.1% | −85.6% |
| Diluted EPS | $-0.22 | $-0.59 | $-0.55 | $-0.61 | $-0.31 | $-0.32 |
| EBITDA | -$1.3M | -$1.7M | -$1.9M | -$1.8M | -$1.4M | -$1.2M |
| Operating cash flow | -$396.1K | -$1.7M | -$659.0K | -$1.8M | -$559.6K | -$1.6M |
| Free cash flow | -$430.2K | -$1.7M | -$659.0K | -$1.9M | -$992.1K | -$1.6M |
| Diluted shares | 5.6M | 5.5M | 4.7M | 4.5M | 4.5M | 3.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $860.3K | $1.4M | $2.1M | $2.8M | $4.2M | $5.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $4.5M | $5.7M | $5.8M | $7.7M | $9.0M | $8.5M |
| Total liabilities | $3.8M | $4.1M | $3.4M | $3.6M | $3.1M | $1.6M |
| Shareholders' equity | $681.9K | $1.6M | $2.3M | $4.2M | $5.8M | $6.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology